Joseph J. Schulz

Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial

Fairooz F. Kabbinavar, Joseph J. Schulz, Michael McCleod et al. · Journal of Clinical Oncology · 2005 · 932 citations · Full text

Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study

Charles S. Fuchs, John L. Marshall, Edith P. Mitchell et al. · Journal of Clinical Oncology · 2007 · 854 citations

Phase II Study of Oral Capecitabine in Patients With Advanced or Metastatic Pancreatic Cancer

Thomas H. Cartwright, Allen Lee Cohn, Jerry A. Varkey et al. · Journal of Clinical Oncology · 2002 · 94 citations

Surgical Oncology, Oral Capecitabine, Pathology +17

Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer

Elizabeth Poplin, Patricia LoRusso, Jacob J. Lokich et al. · Cancer Chemotherapy and Pharmacology · 1994 · 38 citations

Randomized Clinical Trial, Surgical Oncology, Gastrointestinal Oncology +9

ZD9331 as Second- or Third-Line Therapy in Patients With Advanced Colorectal Cancer

Joseph J. Schulz, Alan Keller, Vikki A. Canfield et al. · American Journal of Clinical Oncology · 2004 · 12 citations

Stable Disease, Medicine, Gastroenterology +10